Top Markets
Coin of the day
Celadon Pharmaceuticals Plc Celadon Pharmaceuticals Plc

Celadon Pharmaceuticals Plc

CEL
Rang in Aktien #40708
Celadon Pharmaceuticals Plc functions as a drug development company,... Celadon Pharmaceuticals Plc functions as a drug development company, concentrating on the discovery, production, and distribution of cannabinoid compounds for certified medical uses. The firm's primary activity involves the indoor, hydroponic cultivation of THC cannabis, which is then incorporated into medicinal products targeting chronic pain. Furthermore, Celadon intends to broaden its research into cannabinoids, exploring their therapeutic applications not only for persistent pain but also for conditions such as autism and multiple sclerosis. Established in 2018, the company maintains its headquarters in London, United Kingdom.
Aktienkurs
$0.00179028
Zuletzt synchronisiert: 2025-07-28
Marktkapitalisierung
$94.61K
Veränderung (1 Tag)
-0.54%
Veränderung (1 Jahr)
0.00%
Land
GB
Handel Celadon Pharmaceuticals Plc (CEL)

Kategorie

Kursverlauf für Celadon Pharmaceuticals Plc (CEL)
Höchster Schlusskurs: $0.01 am 2025-07-01

Niedrigster Schlusskurs: $1.68 am 2022-03-01
Kursverlauf der Aktie von Celadon Pharmaceuticals Plc von 2022 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2025 -94.88%
2024 -84.92%
2023 118.21%
2022 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$171.67 -
DE
$165.47 27.27%
DE
$36.27 22.59%
JP
$232.21 43.17%
CH
$21.32 13.71%
IN